Newborn Hearing Screening-Polish Experience: A Narrative Review
Krzysztof Szyfter1, Wojciech Gawęcki2, Witold Szyfter3
1Institute of Human Genetics, Polish Academy of Sciences, 60-479 Poznan, Poland.
Insights
Poland
Area of Science:
- Neonatal care
- Public health initiatives
- Genetics and hearing loss
Background:
- Universal Neonatal Hearing Screening (UNHS) is vital for early detection of infant hearing loss.
- Hearing impairment affects 2-4 per 1000 newborns, with sensorineural hearing loss being most common.
- Risk factors include genetics, prematurity, and congenital infections like cytomegalovirus.
Purpose of the Study:
- To evaluate the implementation and outcomes of Poland's nationwide UNHS program.
- To identify challenges and areas for improvement in neonatal hearing screening.
- To discuss emerging treatments like gene therapy for hearing loss.
Main Methods:
- Analysis of Poland's national UNHS program data.
- Review of scientific literature on neonatal hearing loss prevalence and risk factors.
- Exploration of advancements in hearing loss treatment, including gene therapy.
Main Results:
- Poland's UNHS program successfully adheres to international standards.
- Key challenges include limited parental awareness and access disparities.
- Gene therapy shows promise as a future treatment for hearing loss.
Conclusions:
- The Polish UNHS program is effective but requires ongoing enhancements.
- Addressing parental awareness and access is crucial for program success.
- Gene therapy represents a hopeful future direction for treating congenital hearing loss.
Abstract:
The Universal Neonatal Hearing Screening (UNHS) program is crucial for the early detection and treatment of hearing impairment in newborns. Poland has successfully implemented a nationwide UNHS program, adhering to international standards. Research indicates that hearing loss affects approximately 2-4 per 1000 infants, with sensorineural hearing loss being the most prevalent. Major risk factors include genetic alterations, craniofacial anomalies, prematurity, hyperbilirubinemia, and congenital infections such as cytomegalovirus. Despite the program's success, challenges related to limited parental awareness and disparities in access highlight the need for continuous improvement in screening and follow-up procedures. Additionally, gene therapy is emerging as a promising treatment for hearing loss. While still experimental, gene therapy could become a key complementary treatment option in the future, offering new hope for those with hearing impairments.
